249 related articles for article (PubMed ID: 8095848)
21. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
Kable EP; Favier D; Parsons PG
Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620
[TBL] [Abstract][Full Text] [Related]
22. Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.
Kang YJ; Emery D; Enger MD
Cell Biol Toxicol; 1991 Jul; 7(3):249-61. PubMed ID: 1933516
[TBL] [Abstract][Full Text] [Related]
23. Effects of D,L-buthionine-S,R-sulfoximine on cellular thiol levels and the oxygen effect in Chinese hamster V79 cells.
Astor MB; Hall EJ; Biaglow JE; Hartog B
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1239-42. PubMed ID: 6469744
[TBL] [Abstract][Full Text] [Related]
24. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
Campbell EB; Hayward ML; Griffith OW
Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
[TBL] [Abstract][Full Text] [Related]
25. Effect of BSO on the radiation response at low (0-4 Gy) doses.
Skov KA; MacPhail HS
Int J Radiat Oncol Biol Phys; 1992; 22(3):533-6. PubMed ID: 1346532
[TBL] [Abstract][Full Text] [Related]
26. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.
Dorr RT; Liddil JD; Soble MJ
Invest New Drugs; 1986; 4(4):305-13. PubMed ID: 3583642
[TBL] [Abstract][Full Text] [Related]
28. L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic mice.
Lippitz BE; Halperin EC; Griffith OW; Colvin OM; Honore G; Ostertag CB; Bigner DD; Friedman HS
Neurosurgery; 1990 Feb; 26(2):255-60. PubMed ID: 2308673
[TBL] [Abstract][Full Text] [Related]
29. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
Lee KS; Kim HK; Moon HS; Hong YS; Kang JH; Kim DJ; Park JG
Korean J Intern Med; 1992 Jul; 7(2):111-7. PubMed ID: 1306072
[TBL] [Abstract][Full Text] [Related]
30. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells.
Cammarata PR; Tse D; Yorio T
Curr Eye Res; 1991 Apr; 10(4):321-30. PubMed ID: 1676962
[TBL] [Abstract][Full Text] [Related]
31. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
Drew R; Miners JO
Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
[TBL] [Abstract][Full Text] [Related]
32. Radiation response of Chinese hamster cells after elevation of intracellular glutathione levels.
Russo A; Mitchell JB
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1243-7. PubMed ID: 6469745
[TBL] [Abstract][Full Text] [Related]
33. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
Guichard M; Lespinasse F; Malaise EP
Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
[TBL] [Abstract][Full Text] [Related]
34. Buthionine sulfoximine-induced glutathione depletion. Its effect on antioxidants, lipid peroxidation and calcium homeostasis in the lung.
Thanislass J; Raveendran M; Devaraj H
Biochem Pharmacol; 1995 Jul; 50(2):229-34. PubMed ID: 7632167
[TBL] [Abstract][Full Text] [Related]
35. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
36. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation.
Leeuwenburgh C; Ji LL
Arch Biochem Biophys; 1995 Feb; 316(2):941-9. PubMed ID: 7864653
[TBL] [Abstract][Full Text] [Related]
37. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
Lespinasse F; Biscay P; Malaise EP; Guichard M
Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766
[TBL] [Abstract][Full Text] [Related]
38. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
[TBL] [Abstract][Full Text] [Related]
39. Glutathione depletion and cytotoxicity of buthionine sulphoximine and SR2508 in rodent and human cells.
Ling CC; Wong RS; Basas RD
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):325-30. PubMed ID: 2137437
[TBL] [Abstract][Full Text] [Related]
40. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
Dierickx PJ
Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):423-6. PubMed ID: 2160706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
